#cancer-researchhealthcare
Read more stories on Hashnode
Articles with this tag
P3 | N=300 | CAPItello-292 (NCT04862663) | Sponsor: AstraZeneca | "Positive high-level results from the CAPItello-291 Phase III trial...demonstrated a...
Background NIVO + chemo and NIVO + IPI demonstrated significant overall survival (OS) benefit vs chemo in previously untreated patients with advanced...
ASCO-GU 2024 (On-demand, Poster) — Datopotamab deruxtecan in locally advanced/metastatic urothelial cancer: Preliminary results from the phase 1...
Background:B7-H3, a member of the B7 superfamily, is highly expressed in various solid tumors, but has limited expression at low level in normal...